Wells Fargo & Company Renalytix PLC Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Renalytix PLC stock. As of the latest transaction made, Wells Fargo & Company holds 175 shares of RNLX stock, worth $43. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175Holding current value
$43% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding RNLX
# of Institutions
29Shares Held
4.42MCall Options Held
0Put Options Held
0-
Gilder Gagnon Howe & CO LLC New York, NY761KShares$190,2770.01% of portfolio
-
Pinnacle Associates LTD696KShares$174,0010.01% of portfolio
-
Pentwater Capital Management LP Naples, FL630KShares$157,5000.01% of portfolio
-
Stifel Financial Corp St. Louis, MO558KShares$139,6000.0% of portfolio
-
Tejara Capital LTD London, X0500KShares$125,0980.16% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $9.36M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...